ChemoCentryx Inc. | Mutual Funds
Mutual Funds that own ChemoCentryx Inc.
Wasatch Small Cap Growth Fund
1,086,829
2.21%
0
0.69%
03/31/2018
FTIF SICAV - Franklin Biotechnology Discovery Fund
923,989
1.88%
-129,900
0.52%
06/30/2018
Vanguard Total Stock Market Index Fund
779,777
1.59%
0
0%
07/31/2018
Franklin Biotechnology Discovery Fund
646,608
1.32%
-97,200
0.59%
03/31/2018
iShares Nasdaq Biotechnology ETF
566,217
1.14%
-7,413
0.08%
09/06/2018
Carmignac Portfolio - Euro Patrimoine
536,438
1.09%
320,890
1.56%
06/29/2018
Carmignac Euro-Patrimoine
489,699
1%
315,150
1.33%
06/29/2018
iShares Russell 2000 ETF
459,658
0.94%
-246
0.01%
09/06/2018
Vanguard Extended Market Index Fund
286,325
0.57%
0
0.01%
07/31/2018
Wasatch Micro Cap Fund
227,158
0.46%
0
0.64%
03/31/2018
| Address |
850 Maude Avenue
Mountain View California 94043
United States
|
|
Employees
|
- |
| Website |
http://www.chemocentryx.com |
| Updated |
07/08/2019 |
| ChemoCentryx, Inc. is a biopharmaceutical company engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. |
